Global EPA & DHA (Omega 3) Ingredients Supply, Demand and Key Producers, 2026-2032
The global EPA & DHA (Omega 3) Ingredients market size is expected to reach $ 3540 million by 2032, rising at a market growth of 5.5% CAGR during the forecast period (2026-2032).
In 2025, global EPA & DHA (Omega 3) Ingredients production reached approximately 135,318 tons, with a average price of 17.8 USD/kg.
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are two long-chain Omega-3 polyunsaturated fatty acids that are vital for human health. They are primarily found in deep-sea cold-water fish, shellfish, and microalgae. Since the human body converts plant-derived fatty acids (ALA) into EPA and DHA with extremely low efficiency, obtaining them directly through diet or nutritional supplements remains the only practical means of maintaining adequate levels within the body.
EPA & DHA (Omega 3) Ingredients are long-chain omega-3 polyunsaturated fatty acids. EPA refers to eicosapentaenoic acid, while DHA refers to docosahexaenoic acid. They are key functional lipids associated with cardiovascular health, neurodevelopment, retinal function, inflammatory modulation, and lipid metabolism. In industrial terms, EPA & DHA (Omega 3) Ingredients are not simply equivalent to generic fish oil; they refer to nutritional ingredients, food additives, pharmaceutical raw materials, and functional health products produced from fish oil, algal oil, krill oil, and certain marine by-product oils through refining, concentration, purification, esterification, re-esterification, microencapsulation, or dosage-form processing. Commercial forms include refined oils, concentrated oils, ethyl ester oils, triglyceride oils, powders, emulsions, softgels, liquid formulations, and pharmaceutical-grade high-purity EPA/DHA ingredients. Major applications include dietary supplements, infant formula, functional food and beverages, clinical nutrition, prescription omega-3 products, and pet nutrition.
The EPA & DHA (Omega 3) Ingredients industry is mainly built around two production models: marine oil extraction and concentration, and microalgae fermentation followed by oil extraction and refining. The marine route uses sources such as Peruvian anchovy, sardine, tuna by-products, mackerel, and cod liver oil, followed by crude oil sourcing, degumming, deacidification, bleaching, deodorization, molecular distillation, esterification/re-esterification, concentration, and antioxidant stabilization to produce refined fish oil, medium-to-high concentration EPA/DHA oils, and premium rTG products. The algal route is built on microalgae strains, fermentation tanks, culture media, extraction, and refining, making it suitable for vegan, sustainable, infant nutrition, and premium supplement applications. Industry gross margins vary significantly: low-concentration refined fish oils and commodity-grade materials are typically around 12%?25%; medium-to-high concentration oils, powders, and customized formulations are around 25%?45%; pharmaceutical-grade high-purity EPA, proprietary algal oils, and high-concentration rTG products can reach around 40%?65%. Actual profitability is influenced by fish oil raw material prices, Peruvian anchovy seasons, oxidative stability, certification systems, regulatory registrations, and long-term customer contracts. The upstream chain focuses on marine resources, algal strains, and fermentation inputs; midstream competition centers on purification, concentration efficiency, odor control, contaminant management, batch consistency, and compliance documentation; downstream demand is driven by supplement brands, infant formula companies, pharmaceutical firms, functional food manufacturers, pet nutrition brands, and CDMO customers.
Market Development Opportunities & Main Driving Factors
The core market opportunity for EPA & DHA (Omega 3) Ingredients is created by the convergence of evidence-based nutrition, sustainable sourcing, and premium dosage-form innovation. Rising consumer awareness of cardiovascular management, maternal and infant nutrition, cognitive health, eye health, and proactive wellness is shifting EPA/DHA from traditional fish oil supplementation into a high-value functional lipid platform. Algal EPA/DHA is particularly attractive because it is independent of marine fisheries and fits vegan, clean-label, sustainable sourcing, and premium infant nutrition requirements. Leading companies are also moving from conventional fish oil toward proprietary algal oils, high-concentration oils, customized formulations, and pharmaceutical-grade ingredients. With the ingredient market returning to growth in 2024, high potency, low odor, smaller serving size, traceability, and compliant labeling are becoming major levers for brand differentiation.
Market Challenges, Risks, & Restraints
The main risks lie in raw material cyclicality, price transmission, quality compliance, and the boundaries of health claims. Fish oil supply is highly exposed to Peruvian anchovy seasons, El Ni?o events, regional quotas, and changes in fatty acid profiles, and the supply volatility after 2023 has made inventory control, long-term procurement, and multi-source sourcing more important. Although fish oil production recovered in 2024, regional declines and pricing pressure still affect margin stability. EPA/DHA is also a nutrition ingredient with strong consumer recognition and high regulatory sensitivity, requiring strict control of contaminants, oxidation indicators, heavy metals, batch traceability, label accuracy, and health claims. For smaller players, weaker raw material bargaining power, limited concentration technology, rising certification costs, and price pressure from downstream brands will continue to compress profitability in low-end products.
Downstream Demand Trends
Downstream demand is moving from single-format fish oil softgels toward multi-scenario, precise-dosage, and better-sensory formulations. Dietary supplements remain one of the largest applications, but growth is shifting toward high-concentration EPA/DHA, smaller softgels, liquid drops, gummies, emulsions, ready-to-drink products, clinical nutrition, and pet health. Infant formula and maternal nutrition emphasize stable DHA supply and high safety standards, while the pharmaceutical segment focuses on high-purity EPA or specific EPA/DHA ratios. Future competition will no longer be determined only by oil price per kilogram; it will depend on sustainability, dosage-form compatibility, odor control, oxidative stability, regulatory documentation, and co-development capability with customers. Integrated producers with algal fermentation, fish oil concentration, pharmaceutical-grade registration, microencapsulation, and finished dosage-form capabilities are positioned to gain stronger pricing power in premium nutrition and professional health markets.
This report studies the global EPA & DHA (Omega 3) Ingredients production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for EPA & DHA (Omega 3) Ingredients and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of EPA & DHA (Omega 3) Ingredients that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global EPA & DHA (Omega 3) Ingredients total production and demand, 2021-2032, (Tons)
Global EPA & DHA (Omega 3) Ingredients total production value, 2021-2032, (USD Million)
Global EPA & DHA (Omega 3) Ingredients production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global EPA & DHA (Omega 3) Ingredients consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: EPA & DHA (Omega 3) Ingredients domestic production, consumption, key domestic manufacturers and share
Global EPA & DHA (Omega 3) Ingredients production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global EPA & DHA (Omega 3) Ingredients production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global EPA & DHA (Omega 3) Ingredients production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global EPA & DHA (Omega 3) Ingredients market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include dsm-firmenich, KD Pharma, Croda, BASF, Yuwang Pharma, Corbion, GC Rieber VivoMega, Pelagia (EPAX), Golden Omega, TASA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World EPA & DHA (Omega 3) Ingredients market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global EPA & DHA (Omega 3) Ingredients Market, By Region:
1. How big is the global EPA & DHA (Omega 3) Ingredients market?
2. What is the demand of the global EPA & DHA (Omega 3) Ingredients market?
3. What is the year over year growth of the global EPA & DHA (Omega 3) Ingredients market?
4. What is the production and production value of the global EPA & DHA (Omega 3) Ingredients market?
5. Who are the key producers in the global EPA & DHA (Omega 3) Ingredients market?
6. What are the growth factors driving the market demand?
In 2025, global EPA & DHA (Omega 3) Ingredients production reached approximately 135,318 tons, with a average price of 17.8 USD/kg.
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are two long-chain Omega-3 polyunsaturated fatty acids that are vital for human health. They are primarily found in deep-sea cold-water fish, shellfish, and microalgae. Since the human body converts plant-derived fatty acids (ALA) into EPA and DHA with extremely low efficiency, obtaining them directly through diet or nutritional supplements remains the only practical means of maintaining adequate levels within the body.
EPA & DHA (Omega 3) Ingredients are long-chain omega-3 polyunsaturated fatty acids. EPA refers to eicosapentaenoic acid, while DHA refers to docosahexaenoic acid. They are key functional lipids associated with cardiovascular health, neurodevelopment, retinal function, inflammatory modulation, and lipid metabolism. In industrial terms, EPA & DHA (Omega 3) Ingredients are not simply equivalent to generic fish oil; they refer to nutritional ingredients, food additives, pharmaceutical raw materials, and functional health products produced from fish oil, algal oil, krill oil, and certain marine by-product oils through refining, concentration, purification, esterification, re-esterification, microencapsulation, or dosage-form processing. Commercial forms include refined oils, concentrated oils, ethyl ester oils, triglyceride oils, powders, emulsions, softgels, liquid formulations, and pharmaceutical-grade high-purity EPA/DHA ingredients. Major applications include dietary supplements, infant formula, functional food and beverages, clinical nutrition, prescription omega-3 products, and pet nutrition.
The EPA & DHA (Omega 3) Ingredients industry is mainly built around two production models: marine oil extraction and concentration, and microalgae fermentation followed by oil extraction and refining. The marine route uses sources such as Peruvian anchovy, sardine, tuna by-products, mackerel, and cod liver oil, followed by crude oil sourcing, degumming, deacidification, bleaching, deodorization, molecular distillation, esterification/re-esterification, concentration, and antioxidant stabilization to produce refined fish oil, medium-to-high concentration EPA/DHA oils, and premium rTG products. The algal route is built on microalgae strains, fermentation tanks, culture media, extraction, and refining, making it suitable for vegan, sustainable, infant nutrition, and premium supplement applications. Industry gross margins vary significantly: low-concentration refined fish oils and commodity-grade materials are typically around 12%?25%; medium-to-high concentration oils, powders, and customized formulations are around 25%?45%; pharmaceutical-grade high-purity EPA, proprietary algal oils, and high-concentration rTG products can reach around 40%?65%. Actual profitability is influenced by fish oil raw material prices, Peruvian anchovy seasons, oxidative stability, certification systems, regulatory registrations, and long-term customer contracts. The upstream chain focuses on marine resources, algal strains, and fermentation inputs; midstream competition centers on purification, concentration efficiency, odor control, contaminant management, batch consistency, and compliance documentation; downstream demand is driven by supplement brands, infant formula companies, pharmaceutical firms, functional food manufacturers, pet nutrition brands, and CDMO customers.
Market Development Opportunities & Main Driving Factors
The core market opportunity for EPA & DHA (Omega 3) Ingredients is created by the convergence of evidence-based nutrition, sustainable sourcing, and premium dosage-form innovation. Rising consumer awareness of cardiovascular management, maternal and infant nutrition, cognitive health, eye health, and proactive wellness is shifting EPA/DHA from traditional fish oil supplementation into a high-value functional lipid platform. Algal EPA/DHA is particularly attractive because it is independent of marine fisheries and fits vegan, clean-label, sustainable sourcing, and premium infant nutrition requirements. Leading companies are also moving from conventional fish oil toward proprietary algal oils, high-concentration oils, customized formulations, and pharmaceutical-grade ingredients. With the ingredient market returning to growth in 2024, high potency, low odor, smaller serving size, traceability, and compliant labeling are becoming major levers for brand differentiation.
Market Challenges, Risks, & Restraints
The main risks lie in raw material cyclicality, price transmission, quality compliance, and the boundaries of health claims. Fish oil supply is highly exposed to Peruvian anchovy seasons, El Ni?o events, regional quotas, and changes in fatty acid profiles, and the supply volatility after 2023 has made inventory control, long-term procurement, and multi-source sourcing more important. Although fish oil production recovered in 2024, regional declines and pricing pressure still affect margin stability. EPA/DHA is also a nutrition ingredient with strong consumer recognition and high regulatory sensitivity, requiring strict control of contaminants, oxidation indicators, heavy metals, batch traceability, label accuracy, and health claims. For smaller players, weaker raw material bargaining power, limited concentration technology, rising certification costs, and price pressure from downstream brands will continue to compress profitability in low-end products.
Downstream Demand Trends
Downstream demand is moving from single-format fish oil softgels toward multi-scenario, precise-dosage, and better-sensory formulations. Dietary supplements remain one of the largest applications, but growth is shifting toward high-concentration EPA/DHA, smaller softgels, liquid drops, gummies, emulsions, ready-to-drink products, clinical nutrition, and pet health. Infant formula and maternal nutrition emphasize stable DHA supply and high safety standards, while the pharmaceutical segment focuses on high-purity EPA or specific EPA/DHA ratios. Future competition will no longer be determined only by oil price per kilogram; it will depend on sustainability, dosage-form compatibility, odor control, oxidative stability, regulatory documentation, and co-development capability with customers. Integrated producers with algal fermentation, fish oil concentration, pharmaceutical-grade registration, microencapsulation, and finished dosage-form capabilities are positioned to gain stronger pricing power in premium nutrition and professional health markets.
This report studies the global EPA & DHA (Omega 3) Ingredients production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for EPA & DHA (Omega 3) Ingredients and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of EPA & DHA (Omega 3) Ingredients that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global EPA & DHA (Omega 3) Ingredients total production and demand, 2021-2032, (Tons)
Global EPA & DHA (Omega 3) Ingredients total production value, 2021-2032, (USD Million)
Global EPA & DHA (Omega 3) Ingredients production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global EPA & DHA (Omega 3) Ingredients consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: EPA & DHA (Omega 3) Ingredients domestic production, consumption, key domestic manufacturers and share
Global EPA & DHA (Omega 3) Ingredients production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global EPA & DHA (Omega 3) Ingredients production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global EPA & DHA (Omega 3) Ingredients production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global EPA & DHA (Omega 3) Ingredients market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include dsm-firmenich, KD Pharma, Croda, BASF, Yuwang Pharma, Corbion, GC Rieber VivoMega, Pelagia (EPAX), Golden Omega, TASA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World EPA & DHA (Omega 3) Ingredients market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global EPA & DHA (Omega 3) Ingredients Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- EPA
- DHA
- Fish Oil EPA and DHA
- Algae Oil EPA and DHA
- Others
- Food Grade
- Pharma Grade
- Feed Grade
- Dietary Supplements
- Fortified Food and Beverages
- Infant Formula
- Pharmaceuticals
- Pet Food
- Others
- dsm-firmenich
- KD Pharma
- Croda
- BASF
- Yuwang Pharma
- Corbion
- GC Rieber VivoMega
- Pelagia (EPAX)
- Golden Omega
- TASA
- KinOmega Biopharm
- Omega Protein
- Huatai Phrama
- AlaskOmega (Wiley Companies)
- Jiangsu Auqi Marine Biotechnology
- Roquette
- Polaris
- Solutex
- Sinomega Biotech Engineering
- Xinzhou Marine Biological Products
- ADM
- Nu-Mega (Clover)
- Guangdong Runke Bioengineering
- Nissui
- Cabio Biotech
- Skuny Bioscience
- Fermentalg
- Renpu Pharmaceuticals
- Xiamen HUISON Biotech
- Xiamen Kingdomway
- Algarithm
- Hubei Fuxing Biological Technology
1. How big is the global EPA & DHA (Omega 3) Ingredients market?
2. What is the demand of the global EPA & DHA (Omega 3) Ingredients market?
3. What is the year over year growth of the global EPA & DHA (Omega 3) Ingredients market?
4. What is the production and production value of the global EPA & DHA (Omega 3) Ingredients market?
5. Who are the key producers in the global EPA & DHA (Omega 3) Ingredients market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 EPA & DHA (Omega 3) Ingredients Introduction
1.2 World EPA & DHA (Omega 3) Ingredients Supply & Forecast
1.2.1 World EPA & DHA (Omega 3) Ingredients Production Value (2021 & 2025 & 2032)
1.2.2 World EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.2.3 World EPA & DHA (Omega 3) Ingredients Pricing Trends (2021-2032)
1.3 World EPA & DHA (Omega 3) Ingredients Production by Region (Based on Production Site)
1.3.1 World EPA & DHA (Omega 3) Ingredients Production Value by Region (2021-2032)
1.3.2 World EPA & DHA (Omega 3) Ingredients Production by Region (2021-2032)
1.3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Region (2021-2032)
1.3.4 North America EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.3.5 Europe EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.3.6 China EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.3.7 Japan EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.3.8 South America EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 EPA & DHA (Omega 3) Ingredients Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 EPA & DHA (Omega 3) Ingredients Major Market Trends
2 DEMAND SUMMARY
2.1 World EPA & DHA (Omega 3) Ingredients Demand (2021-2032)
2.2 World EPA & DHA (Omega 3) Ingredients Consumption by Region
2.2.1 World EPA & DHA (Omega 3) Ingredients Consumption by Region (2021-2026)
2.2.2 World EPA & DHA (Omega 3) Ingredients Consumption Forecast by Region (2027-2032)
2.3 United States EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.4 China EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.5 Europe EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.6 Japan EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.7 South Korea EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.8 ASEAN EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.9 India EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World EPA & DHA (Omega 3) Ingredients Production Value by Manufacturer (2021-2026)
3.2 World EPA & DHA (Omega 3) Ingredients Production by Manufacturer (2021-2026)
3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Manufacturer (2021-2026)
3.4 EPA & DHA (Omega 3) Ingredients Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global EPA & DHA (Omega 3) Ingredients Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for EPA & DHA (Omega 3) Ingredients in 2025
3.5.3 Global Concentration Ratios (CR8) for EPA & DHA (Omega 3) Ingredients in 2025
3.6 EPA & DHA (Omega 3) Ingredients Market: Overall Company Footprint Analysis
3.6.1 EPA & DHA (Omega 3) Ingredients Market: Region Footprint
3.6.2 EPA & DHA (Omega 3) Ingredients Market: Company Product Type Footprint
3.6.3 EPA & DHA (Omega 3) Ingredients Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: EPA & DHA (Omega 3) Ingredients Production Value Comparison
4.1.1 United States VS China: EPA & DHA (Omega 3) Ingredients Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: EPA & DHA (Omega 3) Ingredients Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: EPA & DHA (Omega 3) Ingredients Production Comparison
4.2.1 United States VS China: EPA & DHA (Omega 3) Ingredients Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: EPA & DHA (Omega 3) Ingredients Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: EPA & DHA (Omega 3) Ingredients Consumption Comparison
4.3.1 United States VS China: EPA & DHA (Omega 3) Ingredients Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: EPA & DHA (Omega 3) Ingredients Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based EPA & DHA (Omega 3) Ingredients Manufacturers and Market Share, 2021-2026
4.4.1 United States Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value (2021-2026)
4.4.3 United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production (2021-2026)
4.5 China Based EPA & DHA (Omega 3) Ingredients Manufacturers and Market Share
4.5.1 China Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value (2021-2026)
4.5.3 China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production (2021-2026)
4.6 Rest of World Based EPA & DHA (Omega 3) Ingredients Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World EPA & DHA (Omega 3) Ingredients Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 EPA
5.2.2 DHA
5.3 Market Segment by Type
5.3.1 World EPA & DHA (Omega 3) Ingredients Production by Type (2021-2032)
5.3.2 World EPA & DHA (Omega 3) Ingredients Production Value by Type (2021-2032)
5.3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SOURCE
6.1 World EPA & DHA (Omega 3) Ingredients Market Size Overview by Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Source
6.2.1 Fish Oil EPA and DHA
6.2.2 Algae Oil EPA and DHA
6.2.3 Others
6.3 Market Segment by Source
6.3.1 World EPA & DHA (Omega 3) Ingredients Production by Source (2021-2032)
6.3.2 World EPA & DHA (Omega 3) Ingredients Production Value by Source (2021-2032)
6.3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Source (2021-2032)
7 MARKET ANALYSIS BY GRADE
7.1 World EPA & DHA (Omega 3) Ingredients Market Size Overview by Grade: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Grade
7.2.1 Food Grade
7.2.2 Pharma Grade
7.2.3 Feed Grade
7.3 Market Segment by Grade
7.3.1 World EPA & DHA (Omega 3) Ingredients Production by Grade (2021-2032)
7.3.2 World EPA & DHA (Omega 3) Ingredients Production Value by Grade (2021-2032)
7.3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Grade (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World EPA & DHA (Omega 3) Ingredients Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Dietary Supplements
8.2.2 Fortified Food and Beverages
8.2.3 Infant Formula
8.2.4 Pharmaceuticals
8.2.5 Pet Food
8.2.6 Others
8.3 Market Segment by Application
8.3.1 World EPA & DHA (Omega 3) Ingredients Production by Application (2021-2032)
8.3.2 World EPA & DHA (Omega 3) Ingredients Production Value by Application (2021-2032)
8.3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 dsm-firmenich
9.1.1 dsm-firmenich Details
9.1.2 dsm-firmenich Major Business
9.1.3 dsm-firmenich EPA & DHA (Omega 3) Ingredients Product and Services
9.1.4 dsm-firmenich EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 dsm-firmenich Recent Developments/Updates
9.1.6 dsm-firmenich Competitive Strengths & Weaknesses
9.2 KD Pharma
9.2.1 KD Pharma Details
9.2.2 KD Pharma Major Business
9.2.3 KD Pharma EPA & DHA (Omega 3) Ingredients Product and Services
9.2.4 KD Pharma EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 KD Pharma Recent Developments/Updates
9.2.6 KD Pharma Competitive Strengths & Weaknesses
9.3 Croda
9.3.1 Croda Details
9.3.2 Croda Major Business
9.3.3 Croda EPA & DHA (Omega 3) Ingredients Product and Services
9.3.4 Croda EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Croda Recent Developments/Updates
9.3.6 Croda Competitive Strengths & Weaknesses
9.4 BASF
9.4.1 BASF Details
9.4.2 BASF Major Business
9.4.3 BASF EPA & DHA (Omega 3) Ingredients Product and Services
9.4.4 BASF EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 BASF Recent Developments/Updates
9.4.6 BASF Competitive Strengths & Weaknesses
9.5 Yuwang Pharma
9.5.1 Yuwang Pharma Details
9.5.2 Yuwang Pharma Major Business
9.5.3 Yuwang Pharma EPA & DHA (Omega 3) Ingredients Product and Services
9.5.4 Yuwang Pharma EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Yuwang Pharma Recent Developments/Updates
9.5.6 Yuwang Pharma Competitive Strengths & Weaknesses
9.6 Corbion
9.6.1 Corbion Details
9.6.2 Corbion Major Business
9.6.3 Corbion EPA & DHA (Omega 3) Ingredients Product and Services
9.6.4 Corbion EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Corbion Recent Developments/Updates
9.6.6 Corbion Competitive Strengths & Weaknesses
9.7 GC Rieber VivoMega
9.7.1 GC Rieber VivoMega Details
9.7.2 GC Rieber VivoMega Major Business
9.7.3 GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Product and Services
9.7.4 GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 GC Rieber VivoMega Recent Developments/Updates
9.7.6 GC Rieber VivoMega Competitive Strengths & Weaknesses
9.8 Pelagia (EPAX)
9.8.1 Pelagia (EPAX) Details
9.8.2 Pelagia (EPAX) Major Business
9.8.3 Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Product and Services
9.8.4 Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Pelagia (EPAX) Recent Developments/Updates
9.8.6 Pelagia (EPAX) Competitive Strengths & Weaknesses
9.9 Golden Omega
9.9.1 Golden Omega Details
9.9.2 Golden Omega Major Business
9.9.3 Golden Omega EPA & DHA (Omega 3) Ingredients Product and Services
9.9.4 Golden Omega EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Golden Omega Recent Developments/Updates
9.9.6 Golden Omega Competitive Strengths & Weaknesses
9.10 TASA
9.10.1 TASA Details
9.10.2 TASA Major Business
9.10.3 TASA EPA & DHA (Omega 3) Ingredients Product and Services
9.10.4 TASA EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 TASA Recent Developments/Updates
9.10.6 TASA Competitive Strengths & Weaknesses
9.11 KinOmega Biopharm
9.11.1 KinOmega Biopharm Details
9.11.2 KinOmega Biopharm Major Business
9.11.3 KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Product and Services
9.11.4 KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 KinOmega Biopharm Recent Developments/Updates
9.11.6 KinOmega Biopharm Competitive Strengths & Weaknesses
9.12 Omega Protein
9.12.1 Omega Protein Details
9.12.2 Omega Protein Major Business
9.12.3 Omega Protein EPA & DHA (Omega 3) Ingredients Product and Services
9.12.4 Omega Protein EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Omega Protein Recent Developments/Updates
9.12.6 Omega Protein Competitive Strengths & Weaknesses
9.13 Huatai Phrama
9.13.1 Huatai Phrama Details
9.13.2 Huatai Phrama Major Business
9.13.3 Huatai Phrama EPA & DHA (Omega 3) Ingredients Product and Services
9.13.4 Huatai Phrama EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Huatai Phrama Recent Developments/Updates
9.13.6 Huatai Phrama Competitive Strengths & Weaknesses
9.14 AlaskOmega (Wiley Companies)
9.14.1 AlaskOmega (Wiley Companies) Details
9.14.2 AlaskOmega (Wiley Companies) Major Business
9.14.3 AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Product and Services
9.14.4 AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 AlaskOmega (Wiley Companies) Recent Developments/Updates
9.14.6 AlaskOmega (Wiley Companies) Competitive Strengths & Weaknesses
9.15 Jiangsu Auqi Marine Biotechnology
9.15.1 Jiangsu Auqi Marine Biotechnology Details
9.15.2 Jiangsu Auqi Marine Biotechnology Major Business
9.15.3 Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Product and Services
9.15.4 Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Jiangsu Auqi Marine Biotechnology Recent Developments/Updates
9.15.6 Jiangsu Auqi Marine Biotechnology Competitive Strengths & Weaknesses
9.16 Roquette
9.16.1 Roquette Details
9.16.2 Roquette Major Business
9.16.3 Roquette EPA & DHA (Omega 3) Ingredients Product and Services
9.16.4 Roquette EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Roquette Recent Developments/Updates
9.16.6 Roquette Competitive Strengths & Weaknesses
9.17 Polaris
9.17.1 Polaris Details
9.17.2 Polaris Major Business
9.17.3 Polaris EPA & DHA (Omega 3) Ingredients Product and Services
9.17.4 Polaris EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Polaris Recent Developments/Updates
9.17.6 Polaris Competitive Strengths & Weaknesses
9.18 Solutex
9.18.1 Solutex Details
9.18.2 Solutex Major Business
9.18.3 Solutex EPA & DHA (Omega 3) Ingredients Product and Services
9.18.4 Solutex EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Solutex Recent Developments/Updates
9.18.6 Solutex Competitive Strengths & Weaknesses
9.19 Sinomega Biotech Engineering
9.19.1 Sinomega Biotech Engineering Details
9.19.2 Sinomega Biotech Engineering Major Business
9.19.3 Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Product and Services
9.19.4 Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Sinomega Biotech Engineering Recent Developments/Updates
9.19.6 Sinomega Biotech Engineering Competitive Strengths & Weaknesses
9.20 Xinzhou Marine Biological Products
9.20.1 Xinzhou Marine Biological Products Details
9.20.2 Xinzhou Marine Biological Products Major Business
9.20.3 Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Product and Services
9.20.4 Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Xinzhou Marine Biological Products Recent Developments/Updates
9.20.6 Xinzhou Marine Biological Products Competitive Strengths & Weaknesses
9.21 ADM
9.21.1 ADM Details
9.21.2 ADM Major Business
9.21.3 ADM EPA & DHA (Omega 3) Ingredients Product and Services
9.21.4 ADM EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 ADM Recent Developments/Updates
9.21.6 ADM Competitive Strengths & Weaknesses
9.22 Nu-Mega (Clover)
9.22.1 Nu-Mega (Clover) Details
9.22.2 Nu-Mega (Clover) Major Business
9.22.3 Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Product and Services
9.22.4 Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Nu-Mega (Clover) Recent Developments/Updates
9.22.6 Nu-Mega (Clover) Competitive Strengths & Weaknesses
9.23 Guangdong Runke Bioengineering
9.23.1 Guangdong Runke Bioengineering Details
9.23.2 Guangdong Runke Bioengineering Major Business
9.23.3 Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Product and Services
9.23.4 Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Guangdong Runke Bioengineering Recent Developments/Updates
9.23.6 Guangdong Runke Bioengineering Competitive Strengths & Weaknesses
9.24 Nissui
9.24.1 Nissui Details
9.24.2 Nissui Major Business
9.24.3 Nissui EPA & DHA (Omega 3) Ingredients Product and Services
9.24.4 Nissui EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 Nissui Recent Developments/Updates
9.24.6 Nissui Competitive Strengths & Weaknesses
9.25 Cabio Biotech
9.25.1 Cabio Biotech Details
9.25.2 Cabio Biotech Major Business
9.25.3 Cabio Biotech EPA & DHA (Omega 3) Ingredients Product and Services
9.25.4 Cabio Biotech EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 Cabio Biotech Recent Developments/Updates
9.25.6 Cabio Biotech Competitive Strengths & Weaknesses
9.26 Skuny Bioscience
9.26.1 Skuny Bioscience Details
9.26.2 Skuny Bioscience Major Business
9.26.3 Skuny Bioscience EPA & DHA (Omega 3) Ingredients Product and Services
9.26.4 Skuny Bioscience EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Skuny Bioscience Recent Developments/Updates
9.26.6 Skuny Bioscience Competitive Strengths & Weaknesses
9.27 Fermentalg
9.27.1 Fermentalg Details
9.27.2 Fermentalg Major Business
9.27.3 Fermentalg EPA & DHA (Omega 3) Ingredients Product and Services
9.27.4 Fermentalg EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Fermentalg Recent Developments/Updates
9.27.6 Fermentalg Competitive Strengths & Weaknesses
9.28 Renpu Pharmaceuticals
9.28.1 Renpu Pharmaceuticals Details
9.28.2 Renpu Pharmaceuticals Major Business
9.28.3 Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Product and Services
9.28.4 Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.28.5 Renpu Pharmaceuticals Recent Developments/Updates
9.28.6 Renpu Pharmaceuticals Competitive Strengths & Weaknesses
9.29 Xiamen HUISON Biotech
9.29.1 Xiamen HUISON Biotech Details
9.29.2 Xiamen HUISON Biotech Major Business
9.29.3 Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Product and Services
9.29.4 Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.29.5 Xiamen HUISON Biotech Recent Developments/Updates
9.29.6 Xiamen HUISON Biotech Competitive Strengths & Weaknesses
9.30 Xiamen Kingdomway
9.30.1 Xiamen Kingdomway Details
9.30.2 Xiamen Kingdomway Major Business
9.30.3 Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Product and Services
9.30.4 Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.30.5 Xiamen Kingdomway Recent Developments/Updates
9.30.6 Xiamen Kingdomway Competitive Strengths & Weaknesses
9.31 Algarithm
9.31.1 Algarithm Details
9.31.2 Algarithm Major Business
9.31.3 Algarithm EPA & DHA (Omega 3) Ingredients Product and Services
9.31.4 Algarithm EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.31.5 Algarithm Recent Developments/Updates
9.31.6 Algarithm Competitive Strengths & Weaknesses
9.32 Hubei Fuxing Biological Technology
9.32.1 Hubei Fuxing Biological Technology Details
9.32.2 Hubei Fuxing Biological Technology Major Business
9.32.3 Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Product and Services
9.32.4 Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.32.5 Hubei Fuxing Biological Technology Recent Developments/Updates
9.32.6 Hubei Fuxing Biological Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 EPA & DHA (Omega 3) Ingredients Industry Chain
10.2 EPA & DHA (Omega 3) Ingredients Upstream Analysis
10.2.1 EPA & DHA (Omega 3) Ingredients Core Raw Materials
10.2.2 Main Manufacturers of EPA & DHA (Omega 3) Ingredients Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 EPA & DHA (Omega 3) Ingredients Production Mode
10.6 EPA & DHA (Omega 3) Ingredients Procurement Model
10.7 EPA & DHA (Omega 3) Ingredients Industry Sales Model and Sales Channels
10.7.1 EPA & DHA (Omega 3) Ingredients Sales Model
10.7.2 EPA & DHA (Omega 3) Ingredients Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 EPA & DHA (Omega 3) Ingredients Introduction
1.2 World EPA & DHA (Omega 3) Ingredients Supply & Forecast
1.2.1 World EPA & DHA (Omega 3) Ingredients Production Value (2021 & 2025 & 2032)
1.2.2 World EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.2.3 World EPA & DHA (Omega 3) Ingredients Pricing Trends (2021-2032)
1.3 World EPA & DHA (Omega 3) Ingredients Production by Region (Based on Production Site)
1.3.1 World EPA & DHA (Omega 3) Ingredients Production Value by Region (2021-2032)
1.3.2 World EPA & DHA (Omega 3) Ingredients Production by Region (2021-2032)
1.3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Region (2021-2032)
1.3.4 North America EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.3.5 Europe EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.3.6 China EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.3.7 Japan EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.3.8 South America EPA & DHA (Omega 3) Ingredients Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 EPA & DHA (Omega 3) Ingredients Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 EPA & DHA (Omega 3) Ingredients Major Market Trends
2 DEMAND SUMMARY
2.1 World EPA & DHA (Omega 3) Ingredients Demand (2021-2032)
2.2 World EPA & DHA (Omega 3) Ingredients Consumption by Region
2.2.1 World EPA & DHA (Omega 3) Ingredients Consumption by Region (2021-2026)
2.2.2 World EPA & DHA (Omega 3) Ingredients Consumption Forecast by Region (2027-2032)
2.3 United States EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.4 China EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.5 Europe EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.6 Japan EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.7 South Korea EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.8 ASEAN EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
2.9 India EPA & DHA (Omega 3) Ingredients Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World EPA & DHA (Omega 3) Ingredients Production Value by Manufacturer (2021-2026)
3.2 World EPA & DHA (Omega 3) Ingredients Production by Manufacturer (2021-2026)
3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Manufacturer (2021-2026)
3.4 EPA & DHA (Omega 3) Ingredients Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global EPA & DHA (Omega 3) Ingredients Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for EPA & DHA (Omega 3) Ingredients in 2025
3.5.3 Global Concentration Ratios (CR8) for EPA & DHA (Omega 3) Ingredients in 2025
3.6 EPA & DHA (Omega 3) Ingredients Market: Overall Company Footprint Analysis
3.6.1 EPA & DHA (Omega 3) Ingredients Market: Region Footprint
3.6.2 EPA & DHA (Omega 3) Ingredients Market: Company Product Type Footprint
3.6.3 EPA & DHA (Omega 3) Ingredients Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: EPA & DHA (Omega 3) Ingredients Production Value Comparison
4.1.1 United States VS China: EPA & DHA (Omega 3) Ingredients Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: EPA & DHA (Omega 3) Ingredients Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: EPA & DHA (Omega 3) Ingredients Production Comparison
4.2.1 United States VS China: EPA & DHA (Omega 3) Ingredients Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: EPA & DHA (Omega 3) Ingredients Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: EPA & DHA (Omega 3) Ingredients Consumption Comparison
4.3.1 United States VS China: EPA & DHA (Omega 3) Ingredients Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: EPA & DHA (Omega 3) Ingredients Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based EPA & DHA (Omega 3) Ingredients Manufacturers and Market Share, 2021-2026
4.4.1 United States Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value (2021-2026)
4.4.3 United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production (2021-2026)
4.5 China Based EPA & DHA (Omega 3) Ingredients Manufacturers and Market Share
4.5.1 China Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value (2021-2026)
4.5.3 China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production (2021-2026)
4.6 Rest of World Based EPA & DHA (Omega 3) Ingredients Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World EPA & DHA (Omega 3) Ingredients Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 EPA
5.2.2 DHA
5.3 Market Segment by Type
5.3.1 World EPA & DHA (Omega 3) Ingredients Production by Type (2021-2032)
5.3.2 World EPA & DHA (Omega 3) Ingredients Production Value by Type (2021-2032)
5.3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SOURCE
6.1 World EPA & DHA (Omega 3) Ingredients Market Size Overview by Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Source
6.2.1 Fish Oil EPA and DHA
6.2.2 Algae Oil EPA and DHA
6.2.3 Others
6.3 Market Segment by Source
6.3.1 World EPA & DHA (Omega 3) Ingredients Production by Source (2021-2032)
6.3.2 World EPA & DHA (Omega 3) Ingredients Production Value by Source (2021-2032)
6.3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Source (2021-2032)
7 MARKET ANALYSIS BY GRADE
7.1 World EPA & DHA (Omega 3) Ingredients Market Size Overview by Grade: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Grade
7.2.1 Food Grade
7.2.2 Pharma Grade
7.2.3 Feed Grade
7.3 Market Segment by Grade
7.3.1 World EPA & DHA (Omega 3) Ingredients Production by Grade (2021-2032)
7.3.2 World EPA & DHA (Omega 3) Ingredients Production Value by Grade (2021-2032)
7.3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Grade (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World EPA & DHA (Omega 3) Ingredients Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Dietary Supplements
8.2.2 Fortified Food and Beverages
8.2.3 Infant Formula
8.2.4 Pharmaceuticals
8.2.5 Pet Food
8.2.6 Others
8.3 Market Segment by Application
8.3.1 World EPA & DHA (Omega 3) Ingredients Production by Application (2021-2032)
8.3.2 World EPA & DHA (Omega 3) Ingredients Production Value by Application (2021-2032)
8.3.3 World EPA & DHA (Omega 3) Ingredients Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 dsm-firmenich
9.1.1 dsm-firmenich Details
9.1.2 dsm-firmenich Major Business
9.1.3 dsm-firmenich EPA & DHA (Omega 3) Ingredients Product and Services
9.1.4 dsm-firmenich EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 dsm-firmenich Recent Developments/Updates
9.1.6 dsm-firmenich Competitive Strengths & Weaknesses
9.2 KD Pharma
9.2.1 KD Pharma Details
9.2.2 KD Pharma Major Business
9.2.3 KD Pharma EPA & DHA (Omega 3) Ingredients Product and Services
9.2.4 KD Pharma EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 KD Pharma Recent Developments/Updates
9.2.6 KD Pharma Competitive Strengths & Weaknesses
9.3 Croda
9.3.1 Croda Details
9.3.2 Croda Major Business
9.3.3 Croda EPA & DHA (Omega 3) Ingredients Product and Services
9.3.4 Croda EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Croda Recent Developments/Updates
9.3.6 Croda Competitive Strengths & Weaknesses
9.4 BASF
9.4.1 BASF Details
9.4.2 BASF Major Business
9.4.3 BASF EPA & DHA (Omega 3) Ingredients Product and Services
9.4.4 BASF EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 BASF Recent Developments/Updates
9.4.6 BASF Competitive Strengths & Weaknesses
9.5 Yuwang Pharma
9.5.1 Yuwang Pharma Details
9.5.2 Yuwang Pharma Major Business
9.5.3 Yuwang Pharma EPA & DHA (Omega 3) Ingredients Product and Services
9.5.4 Yuwang Pharma EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Yuwang Pharma Recent Developments/Updates
9.5.6 Yuwang Pharma Competitive Strengths & Weaknesses
9.6 Corbion
9.6.1 Corbion Details
9.6.2 Corbion Major Business
9.6.3 Corbion EPA & DHA (Omega 3) Ingredients Product and Services
9.6.4 Corbion EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Corbion Recent Developments/Updates
9.6.6 Corbion Competitive Strengths & Weaknesses
9.7 GC Rieber VivoMega
9.7.1 GC Rieber VivoMega Details
9.7.2 GC Rieber VivoMega Major Business
9.7.3 GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Product and Services
9.7.4 GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 GC Rieber VivoMega Recent Developments/Updates
9.7.6 GC Rieber VivoMega Competitive Strengths & Weaknesses
9.8 Pelagia (EPAX)
9.8.1 Pelagia (EPAX) Details
9.8.2 Pelagia (EPAX) Major Business
9.8.3 Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Product and Services
9.8.4 Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Pelagia (EPAX) Recent Developments/Updates
9.8.6 Pelagia (EPAX) Competitive Strengths & Weaknesses
9.9 Golden Omega
9.9.1 Golden Omega Details
9.9.2 Golden Omega Major Business
9.9.3 Golden Omega EPA & DHA (Omega 3) Ingredients Product and Services
9.9.4 Golden Omega EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Golden Omega Recent Developments/Updates
9.9.6 Golden Omega Competitive Strengths & Weaknesses
9.10 TASA
9.10.1 TASA Details
9.10.2 TASA Major Business
9.10.3 TASA EPA & DHA (Omega 3) Ingredients Product and Services
9.10.4 TASA EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 TASA Recent Developments/Updates
9.10.6 TASA Competitive Strengths & Weaknesses
9.11 KinOmega Biopharm
9.11.1 KinOmega Biopharm Details
9.11.2 KinOmega Biopharm Major Business
9.11.3 KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Product and Services
9.11.4 KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 KinOmega Biopharm Recent Developments/Updates
9.11.6 KinOmega Biopharm Competitive Strengths & Weaknesses
9.12 Omega Protein
9.12.1 Omega Protein Details
9.12.2 Omega Protein Major Business
9.12.3 Omega Protein EPA & DHA (Omega 3) Ingredients Product and Services
9.12.4 Omega Protein EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Omega Protein Recent Developments/Updates
9.12.6 Omega Protein Competitive Strengths & Weaknesses
9.13 Huatai Phrama
9.13.1 Huatai Phrama Details
9.13.2 Huatai Phrama Major Business
9.13.3 Huatai Phrama EPA & DHA (Omega 3) Ingredients Product and Services
9.13.4 Huatai Phrama EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Huatai Phrama Recent Developments/Updates
9.13.6 Huatai Phrama Competitive Strengths & Weaknesses
9.14 AlaskOmega (Wiley Companies)
9.14.1 AlaskOmega (Wiley Companies) Details
9.14.2 AlaskOmega (Wiley Companies) Major Business
9.14.3 AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Product and Services
9.14.4 AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 AlaskOmega (Wiley Companies) Recent Developments/Updates
9.14.6 AlaskOmega (Wiley Companies) Competitive Strengths & Weaknesses
9.15 Jiangsu Auqi Marine Biotechnology
9.15.1 Jiangsu Auqi Marine Biotechnology Details
9.15.2 Jiangsu Auqi Marine Biotechnology Major Business
9.15.3 Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Product and Services
9.15.4 Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Jiangsu Auqi Marine Biotechnology Recent Developments/Updates
9.15.6 Jiangsu Auqi Marine Biotechnology Competitive Strengths & Weaknesses
9.16 Roquette
9.16.1 Roquette Details
9.16.2 Roquette Major Business
9.16.3 Roquette EPA & DHA (Omega 3) Ingredients Product and Services
9.16.4 Roquette EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Roquette Recent Developments/Updates
9.16.6 Roquette Competitive Strengths & Weaknesses
9.17 Polaris
9.17.1 Polaris Details
9.17.2 Polaris Major Business
9.17.3 Polaris EPA & DHA (Omega 3) Ingredients Product and Services
9.17.4 Polaris EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Polaris Recent Developments/Updates
9.17.6 Polaris Competitive Strengths & Weaknesses
9.18 Solutex
9.18.1 Solutex Details
9.18.2 Solutex Major Business
9.18.3 Solutex EPA & DHA (Omega 3) Ingredients Product and Services
9.18.4 Solutex EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Solutex Recent Developments/Updates
9.18.6 Solutex Competitive Strengths & Weaknesses
9.19 Sinomega Biotech Engineering
9.19.1 Sinomega Biotech Engineering Details
9.19.2 Sinomega Biotech Engineering Major Business
9.19.3 Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Product and Services
9.19.4 Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Sinomega Biotech Engineering Recent Developments/Updates
9.19.6 Sinomega Biotech Engineering Competitive Strengths & Weaknesses
9.20 Xinzhou Marine Biological Products
9.20.1 Xinzhou Marine Biological Products Details
9.20.2 Xinzhou Marine Biological Products Major Business
9.20.3 Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Product and Services
9.20.4 Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Xinzhou Marine Biological Products Recent Developments/Updates
9.20.6 Xinzhou Marine Biological Products Competitive Strengths & Weaknesses
9.21 ADM
9.21.1 ADM Details
9.21.2 ADM Major Business
9.21.3 ADM EPA & DHA (Omega 3) Ingredients Product and Services
9.21.4 ADM EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 ADM Recent Developments/Updates
9.21.6 ADM Competitive Strengths & Weaknesses
9.22 Nu-Mega (Clover)
9.22.1 Nu-Mega (Clover) Details
9.22.2 Nu-Mega (Clover) Major Business
9.22.3 Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Product and Services
9.22.4 Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Nu-Mega (Clover) Recent Developments/Updates
9.22.6 Nu-Mega (Clover) Competitive Strengths & Weaknesses
9.23 Guangdong Runke Bioengineering
9.23.1 Guangdong Runke Bioengineering Details
9.23.2 Guangdong Runke Bioengineering Major Business
9.23.3 Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Product and Services
9.23.4 Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Guangdong Runke Bioengineering Recent Developments/Updates
9.23.6 Guangdong Runke Bioengineering Competitive Strengths & Weaknesses
9.24 Nissui
9.24.1 Nissui Details
9.24.2 Nissui Major Business
9.24.3 Nissui EPA & DHA (Omega 3) Ingredients Product and Services
9.24.4 Nissui EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 Nissui Recent Developments/Updates
9.24.6 Nissui Competitive Strengths & Weaknesses
9.25 Cabio Biotech
9.25.1 Cabio Biotech Details
9.25.2 Cabio Biotech Major Business
9.25.3 Cabio Biotech EPA & DHA (Omega 3) Ingredients Product and Services
9.25.4 Cabio Biotech EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 Cabio Biotech Recent Developments/Updates
9.25.6 Cabio Biotech Competitive Strengths & Weaknesses
9.26 Skuny Bioscience
9.26.1 Skuny Bioscience Details
9.26.2 Skuny Bioscience Major Business
9.26.3 Skuny Bioscience EPA & DHA (Omega 3) Ingredients Product and Services
9.26.4 Skuny Bioscience EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Skuny Bioscience Recent Developments/Updates
9.26.6 Skuny Bioscience Competitive Strengths & Weaknesses
9.27 Fermentalg
9.27.1 Fermentalg Details
9.27.2 Fermentalg Major Business
9.27.3 Fermentalg EPA & DHA (Omega 3) Ingredients Product and Services
9.27.4 Fermentalg EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Fermentalg Recent Developments/Updates
9.27.6 Fermentalg Competitive Strengths & Weaknesses
9.28 Renpu Pharmaceuticals
9.28.1 Renpu Pharmaceuticals Details
9.28.2 Renpu Pharmaceuticals Major Business
9.28.3 Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Product and Services
9.28.4 Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.28.5 Renpu Pharmaceuticals Recent Developments/Updates
9.28.6 Renpu Pharmaceuticals Competitive Strengths & Weaknesses
9.29 Xiamen HUISON Biotech
9.29.1 Xiamen HUISON Biotech Details
9.29.2 Xiamen HUISON Biotech Major Business
9.29.3 Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Product and Services
9.29.4 Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.29.5 Xiamen HUISON Biotech Recent Developments/Updates
9.29.6 Xiamen HUISON Biotech Competitive Strengths & Weaknesses
9.30 Xiamen Kingdomway
9.30.1 Xiamen Kingdomway Details
9.30.2 Xiamen Kingdomway Major Business
9.30.3 Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Product and Services
9.30.4 Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.30.5 Xiamen Kingdomway Recent Developments/Updates
9.30.6 Xiamen Kingdomway Competitive Strengths & Weaknesses
9.31 Algarithm
9.31.1 Algarithm Details
9.31.2 Algarithm Major Business
9.31.3 Algarithm EPA & DHA (Omega 3) Ingredients Product and Services
9.31.4 Algarithm EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.31.5 Algarithm Recent Developments/Updates
9.31.6 Algarithm Competitive Strengths & Weaknesses
9.32 Hubei Fuxing Biological Technology
9.32.1 Hubei Fuxing Biological Technology Details
9.32.2 Hubei Fuxing Biological Technology Major Business
9.32.3 Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Product and Services
9.32.4 Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.32.5 Hubei Fuxing Biological Technology Recent Developments/Updates
9.32.6 Hubei Fuxing Biological Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 EPA & DHA (Omega 3) Ingredients Industry Chain
10.2 EPA & DHA (Omega 3) Ingredients Upstream Analysis
10.2.1 EPA & DHA (Omega 3) Ingredients Core Raw Materials
10.2.2 Main Manufacturers of EPA & DHA (Omega 3) Ingredients Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 EPA & DHA (Omega 3) Ingredients Production Mode
10.6 EPA & DHA (Omega 3) Ingredients Procurement Model
10.7 EPA & DHA (Omega 3) Ingredients Industry Sales Model and Sales Channels
10.7.1 EPA & DHA (Omega 3) Ingredients Sales Model
10.7.2 EPA & DHA (Omega 3) Ingredients Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World EPA & DHA (Omega 3) Ingredients Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World EPA & DHA (Omega 3) Ingredients Production Value by Region (2021-2026) & (USD Million)
Table 3. World EPA & DHA (Omega 3) Ingredients Production Value by Region (2027-2032) & (USD Million)
Table 4. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Region (2021-2026)
Table 5. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Region (2027-2032)
Table 6. World EPA & DHA (Omega 3) Ingredients Production by Region (2021-2026) & (Tons)
Table 7. World EPA & DHA (Omega 3) Ingredients Production by Region (2027-2032) & (Tons)
Table 8. World EPA & DHA (Omega 3) Ingredients Production Market Share by Region (2021-2026)
Table 9. World EPA & DHA (Omega 3) Ingredients Production Market Share by Region (2027-2032)
Table 10. World EPA & DHA (Omega 3) Ingredients Average Price by Region (2021-2026) & (US$/kg)
Table 11. World EPA & DHA (Omega 3) Ingredients Average Price by Region (2027-2032) & (US$/kg)
Table 12. EPA & DHA (Omega 3) Ingredients Major Market Trends
Table 13. World EPA & DHA (Omega 3) Ingredients Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World EPA & DHA (Omega 3) Ingredients Consumption by Region (2021-2026) & (Tons)
Table 15. World EPA & DHA (Omega 3) Ingredients Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World EPA & DHA (Omega 3) Ingredients Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key EPA & DHA (Omega 3) Ingredients Producers in 2025
Table 18. World EPA & DHA (Omega 3) Ingredients Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key EPA & DHA (Omega 3) Ingredients Producers in 2025
Table 20. World EPA & DHA (Omega 3) Ingredients Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global EPA & DHA (Omega 3) Ingredients Company Evaluation Quadrant
Table 22. World EPA & DHA (Omega 3) Ingredients Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and EPA & DHA (Omega 3) Ingredients Production Site of Key Manufacturer
Table 24. EPA & DHA (Omega 3) Ingredients Market: Company Product Type Footprint
Table 25. EPA & DHA (Omega 3) Ingredients Market: Company Product Application Footprint
Table 26. EPA & DHA (Omega 3) Ingredients Competitive Factors
Table 27. EPA & DHA (Omega 3) Ingredients New Entrant and Capacity Expansion Plans
Table 28. EPA & DHA (Omega 3) Ingredients Mergers & Acquisitions Activity
Table 29. United States VS China EPA & DHA (Omega 3) Ingredients Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China EPA & DHA (Omega 3) Ingredients Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China EPA & DHA (Omega 3) Ingredients Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share (2021-2026)
Table 37. China Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share (2021-2026)
Table 42. Rest of World Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share (2021-2026)
Table 47. World EPA & DHA (Omega 3) Ingredients Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World EPA & DHA (Omega 3) Ingredients Production by Type (2021-2026) & (Tons)
Table 49. World EPA & DHA (Omega 3) Ingredients Production by Type (2027-2032) & (Tons)
Table 50. World EPA & DHA (Omega 3) Ingredients Production Value by Type (2021-2026) & (USD Million)
Table 51. World EPA & DHA (Omega 3) Ingredients Production Value by Type (2027-2032) & (USD Million)
Table 52. World EPA & DHA (Omega 3) Ingredients Average Price by Type (2021-2026) & (US$/kg)
Table 53. World EPA & DHA (Omega 3) Ingredients Average Price by Type (2027-2032) & (US$/kg)
Table 54. World EPA & DHA (Omega 3) Ingredients Production Value by Source, (USD Million), 2021 & 2025 & 2032
Table 55. World EPA & DHA (Omega 3) Ingredients Production by Source (2021-2026) & (Tons)
Table 56. World EPA & DHA (Omega 3) Ingredients Production by Source (2027-2032) & (Tons)
Table 57. World EPA & DHA (Omega 3) Ingredients Production Value by Source (2021-2026) & (USD Million)
Table 58. World EPA & DHA (Omega 3) Ingredients Production Value by Source (2027-2032) & (USD Million)
Table 59. World EPA & DHA (Omega 3) Ingredients Average Price by Source (2021-2026) & (US$/kg)
Table 60. World EPA & DHA (Omega 3) Ingredients Average Price by Source (2027-2032) & (US$/kg)
Table 61. World EPA & DHA (Omega 3) Ingredients Production Value by Grade, (USD Million), 2021 & 2025 & 2032
Table 62. World EPA & DHA (Omega 3) Ingredients Production by Grade (2021-2026) & (Tons)
Table 63. World EPA & DHA (Omega 3) Ingredients Production by Grade (2027-2032) & (Tons)
Table 64. World EPA & DHA (Omega 3) Ingredients Production Value by Grade (2021-2026) & (USD Million)
Table 65. World EPA & DHA (Omega 3) Ingredients Production Value by Grade (2027-2032) & (USD Million)
Table 66. World EPA & DHA (Omega 3) Ingredients Average Price by Grade (2021-2026) & (US$/kg)
Table 67. World EPA & DHA (Omega 3) Ingredients Average Price by Grade (2027-2032) & (US$/kg)
Table 68. World EPA & DHA (Omega 3) Ingredients Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World EPA & DHA (Omega 3) Ingredients Production by Application (2021-2026) & (Tons)
Table 70. World EPA & DHA (Omega 3) Ingredients Production by Application (2027-2032) & (Tons)
Table 71. World EPA & DHA (Omega 3) Ingredients Production Value by Application (2021-2026) & (USD Million)
Table 72. World EPA & DHA (Omega 3) Ingredients Production Value by Application (2027-2032) & (USD Million)
Table 73. World EPA & DHA (Omega 3) Ingredients Average Price by Application (2021-2026) & (US$/kg)
Table 74. World EPA & DHA (Omega 3) Ingredients Average Price by Application (2027-2032) & (US$/kg)
Table 75. dsm-firmenich Basic Information, Manufacturing Base and Competitors
Table 76. dsm-firmenich Major Business
Table 77. dsm-firmenich EPA & DHA (Omega 3) Ingredients Product and Services
Table 78. dsm-firmenich EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. dsm-firmenich Recent Developments/Updates
Table 80. dsm-firmenich Competitive Strengths & Weaknesses
Table 81. KD Pharma Basic Information, Manufacturing Base and Competitors
Table 82. KD Pharma Major Business
Table 83. KD Pharma EPA & DHA (Omega 3) Ingredients Product and Services
Table 84. KD Pharma EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. KD Pharma Recent Developments/Updates
Table 86. KD Pharma Competitive Strengths & Weaknesses
Table 87. Croda Basic Information, Manufacturing Base and Competitors
Table 88. Croda Major Business
Table 89. Croda EPA & DHA (Omega 3) Ingredients Product and Services
Table 90. Croda EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Croda Recent Developments/Updates
Table 92. Croda Competitive Strengths & Weaknesses
Table 93. BASF Basic Information, Manufacturing Base and Competitors
Table 94. BASF Major Business
Table 95. BASF EPA & DHA (Omega 3) Ingredients Product and Services
Table 96. BASF EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. BASF Recent Developments/Updates
Table 98. BASF Competitive Strengths & Weaknesses
Table 99. Yuwang Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Yuwang Pharma Major Business
Table 101. Yuwang Pharma EPA & DHA (Omega 3) Ingredients Product and Services
Table 102. Yuwang Pharma EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Yuwang Pharma Recent Developments/Updates
Table 104. Yuwang Pharma Competitive Strengths & Weaknesses
Table 105. Corbion Basic Information, Manufacturing Base and Competitors
Table 106. Corbion Major Business
Table 107. Corbion EPA & DHA (Omega 3) Ingredients Product and Services
Table 108. Corbion EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Corbion Recent Developments/Updates
Table 110. Corbion Competitive Strengths & Weaknesses
Table 111. GC Rieber VivoMega Basic Information, Manufacturing Base and Competitors
Table 112. GC Rieber VivoMega Major Business
Table 113. GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Product and Services
Table 114. GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. GC Rieber VivoMega Recent Developments/Updates
Table 116. GC Rieber VivoMega Competitive Strengths & Weaknesses
Table 117. Pelagia (EPAX) Basic Information, Manufacturing Base and Competitors
Table 118. Pelagia (EPAX) Major Business
Table 119. Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Product and Services
Table 120. Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Pelagia (EPAX) Recent Developments/Updates
Table 122. Pelagia (EPAX) Competitive Strengths & Weaknesses
Table 123. Golden Omega Basic Information, Manufacturing Base and Competitors
Table 124. Golden Omega Major Business
Table 125. Golden Omega EPA & DHA (Omega 3) Ingredients Product and Services
Table 126. Golden Omega EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Golden Omega Recent Developments/Updates
Table 128. Golden Omega Competitive Strengths & Weaknesses
Table 129. TASA Basic Information, Manufacturing Base and Competitors
Table 130. TASA Major Business
Table 131. TASA EPA & DHA (Omega 3) Ingredients Product and Services
Table 132. TASA EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. TASA Recent Developments/Updates
Table 134. TASA Competitive Strengths & Weaknesses
Table 135. KinOmega Biopharm Basic Information, Manufacturing Base and Competitors
Table 136. KinOmega Biopharm Major Business
Table 137. KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Product and Services
Table 138. KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. KinOmega Biopharm Recent Developments/Updates
Table 140. KinOmega Biopharm Competitive Strengths & Weaknesses
Table 141. Omega Protein Basic Information, Manufacturing Base and Competitors
Table 142. Omega Protein Major Business
Table 143. Omega Protein EPA & DHA (Omega 3) Ingredients Product and Services
Table 144. Omega Protein EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Omega Protein Recent Developments/Updates
Table 146. Omega Protein Competitive Strengths & Weaknesses
Table 147. Huatai Phrama Basic Information, Manufacturing Base and Competitors
Table 148. Huatai Phrama Major Business
Table 149. Huatai Phrama EPA & DHA (Omega 3) Ingredients Product and Services
Table 150. Huatai Phrama EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Huatai Phrama Recent Developments/Updates
Table 152. Huatai Phrama Competitive Strengths & Weaknesses
Table 153. AlaskOmega (Wiley Companies) Basic Information, Manufacturing Base and Competitors
Table 154. AlaskOmega (Wiley Companies) Major Business
Table 155. AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Product and Services
Table 156. AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. AlaskOmega (Wiley Companies) Recent Developments/Updates
Table 158. AlaskOmega (Wiley Companies) Competitive Strengths & Weaknesses
Table 159. Jiangsu Auqi Marine Biotechnology Basic Information, Manufacturing Base and Competitors
Table 160. Jiangsu Auqi Marine Biotechnology Major Business
Table 161. Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Product and Services
Table 162. Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Jiangsu Auqi Marine Biotechnology Recent Developments/Updates
Table 164. Jiangsu Auqi Marine Biotechnology Competitive Strengths & Weaknesses
Table 165. Roquette Basic Information, Manufacturing Base and Competitors
Table 166. Roquette Major Business
Table 167. Roquette EPA & DHA (Omega 3) Ingredients Product and Services
Table 168. Roquette EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Roquette Recent Developments/Updates
Table 170. Roquette Competitive Strengths & Weaknesses
Table 171. Polaris Basic Information, Manufacturing Base and Competitors
Table 172. Polaris Major Business
Table 173. Polaris EPA & DHA (Omega 3) Ingredients Product and Services
Table 174. Polaris EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Polaris Recent Developments/Updates
Table 176. Polaris Competitive Strengths & Weaknesses
Table 177. Solutex Basic Information, Manufacturing Base and Competitors
Table 178. Solutex Major Business
Table 179. Solutex EPA & DHA (Omega 3) Ingredients Product and Services
Table 180. Solutex EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Solutex Recent Developments/Updates
Table 182. Solutex Competitive Strengths & Weaknesses
Table 183. Sinomega Biotech Engineering Basic Information, Manufacturing Base and Competitors
Table 184. Sinomega Biotech Engineering Major Business
Table 185. Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Product and Services
Table 186. Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Sinomega Biotech Engineering Recent Developments/Updates
Table 188. Sinomega Biotech Engineering Competitive Strengths & Weaknesses
Table 189. Xinzhou Marine Biological Products Basic Information, Manufacturing Base and Competitors
Table 190. Xinzhou Marine Biological Products Major Business
Table 191. Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Product and Services
Table 192. Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Xinzhou Marine Biological Products Recent Developments/Updates
Table 194. Xinzhou Marine Biological Products Competitive Strengths & Weaknesses
Table 195. ADM Basic Information, Manufacturing Base and Competitors
Table 196. ADM Major Business
Table 197. ADM EPA & DHA (Omega 3) Ingredients Product and Services
Table 198. ADM EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. ADM Recent Developments/Updates
Table 200. ADM Competitive Strengths & Weaknesses
Table 201. Nu-Mega (Clover) Basic Information, Manufacturing Base and Competitors
Table 202. Nu-Mega (Clover) Major Business
Table 203. Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Product and Services
Table 204. Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Nu-Mega (Clover) Recent Developments/Updates
Table 206. Nu-Mega (Clover) Competitive Strengths & Weaknesses
Table 207. Guangdong Runke Bioengineering Basic Information, Manufacturing Base and Competitors
Table 208. Guangdong Runke Bioengineering Major Business
Table 209. Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Product and Services
Table 210. Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Guangdong Runke Bioengineering Recent Developments/Updates
Table 212. Guangdong Runke Bioengineering Competitive Strengths & Weaknesses
Table 213. Nissui Basic Information, Manufacturing Base and Competitors
Table 214. Nissui Major Business
Table 215. Nissui EPA & DHA (Omega 3) Ingredients Product and Services
Table 216. Nissui EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. Nissui Recent Developments/Updates
Table 218. Nissui Competitive Strengths & Weaknesses
Table 219. Cabio Biotech Basic Information, Manufacturing Base and Competitors
Table 220. Cabio Biotech Major Business
Table 221. Cabio Biotech EPA & DHA (Omega 3) Ingredients Product and Services
Table 222. Cabio Biotech EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. Cabio Biotech Recent Developments/Updates
Table 224. Cabio Biotech Competitive Strengths & Weaknesses
Table 225. Skuny Bioscience Basic Information, Manufacturing Base and Competitors
Table 226. Skuny Bioscience Major Business
Table 227. Skuny Bioscience EPA & DHA (Omega 3) Ingredients Product and Services
Table 228. Skuny Bioscience EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Skuny Bioscience Recent Developments/Updates
Table 230. Skuny Bioscience Competitive Strengths & Weaknesses
Table 231. Fermentalg Basic Information, Manufacturing Base and Competitors
Table 232. Fermentalg Major Business
Table 233. Fermentalg EPA & DHA (Omega 3) Ingredients Product and Services
Table 234. Fermentalg EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Fermentalg Recent Developments/Updates
Table 236. Fermentalg Competitive Strengths & Weaknesses
Table 237. Renpu Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 238. Renpu Pharmaceuticals Major Business
Table 239. Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Product and Services
Table 240. Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 241. Renpu Pharmaceuticals Recent Developments/Updates
Table 242. Renpu Pharmaceuticals Competitive Strengths & Weaknesses
Table 243. Xiamen HUISON Biotech Basic Information, Manufacturing Base and Competitors
Table 244. Xiamen HUISON Biotech Major Business
Table 245. Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Product and Services
Table 246. Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 247. Xiamen HUISON Biotech Recent Developments/Updates
Table 248. Xiamen HUISON Biotech Competitive Strengths & Weaknesses
Table 249. Xiamen Kingdomway Basic Information, Manufacturing Base and Competitors
Table 250. Xiamen Kingdomway Major Business
Table 251. Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Product and Services
Table 252. Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 253. Xiamen Kingdomway Recent Developments/Updates
Table 254. Xiamen Kingdomway Competitive Strengths & Weaknesses
Table 255. Algarithm Basic Information, Manufacturing Base and Competitors
Table 256. Algarithm Major Business
Table 257. Algarithm EPA & DHA (Omega 3) Ingredients Product and Services
Table 258. Algarithm EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 259. Algarithm Recent Developments/Updates
Table 260. Algarithm Competitive Strengths & Weaknesses
Table 261. Hubei Fuxing Biological Technology Basic Information, Manufacturing Base and Competitors
Table 262. Hubei Fuxing Biological Technology Major Business
Table 263. Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Product and Services
Table 264. Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 265. Hubei Fuxing Biological Technology Recent Developments/Updates
Table 266. Hubei Fuxing Biological Technology Competitive Strengths & Weaknesses
Table 267. Global Key Players of EPA & DHA (Omega 3) Ingredients Upstream (Raw Materials)
Table 268. Global EPA & DHA (Omega 3) Ingredients Typical Customers
Table 269. EPA & DHA (Omega 3) Ingredients Typical Distributors
Table 1. World EPA & DHA (Omega 3) Ingredients Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World EPA & DHA (Omega 3) Ingredients Production Value by Region (2021-2026) & (USD Million)
Table 3. World EPA & DHA (Omega 3) Ingredients Production Value by Region (2027-2032) & (USD Million)
Table 4. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Region (2021-2026)
Table 5. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Region (2027-2032)
Table 6. World EPA & DHA (Omega 3) Ingredients Production by Region (2021-2026) & (Tons)
Table 7. World EPA & DHA (Omega 3) Ingredients Production by Region (2027-2032) & (Tons)
Table 8. World EPA & DHA (Omega 3) Ingredients Production Market Share by Region (2021-2026)
Table 9. World EPA & DHA (Omega 3) Ingredients Production Market Share by Region (2027-2032)
Table 10. World EPA & DHA (Omega 3) Ingredients Average Price by Region (2021-2026) & (US$/kg)
Table 11. World EPA & DHA (Omega 3) Ingredients Average Price by Region (2027-2032) & (US$/kg)
Table 12. EPA & DHA (Omega 3) Ingredients Major Market Trends
Table 13. World EPA & DHA (Omega 3) Ingredients Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World EPA & DHA (Omega 3) Ingredients Consumption by Region (2021-2026) & (Tons)
Table 15. World EPA & DHA (Omega 3) Ingredients Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World EPA & DHA (Omega 3) Ingredients Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key EPA & DHA (Omega 3) Ingredients Producers in 2025
Table 18. World EPA & DHA (Omega 3) Ingredients Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key EPA & DHA (Omega 3) Ingredients Producers in 2025
Table 20. World EPA & DHA (Omega 3) Ingredients Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global EPA & DHA (Omega 3) Ingredients Company Evaluation Quadrant
Table 22. World EPA & DHA (Omega 3) Ingredients Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and EPA & DHA (Omega 3) Ingredients Production Site of Key Manufacturer
Table 24. EPA & DHA (Omega 3) Ingredients Market: Company Product Type Footprint
Table 25. EPA & DHA (Omega 3) Ingredients Market: Company Product Application Footprint
Table 26. EPA & DHA (Omega 3) Ingredients Competitive Factors
Table 27. EPA & DHA (Omega 3) Ingredients New Entrant and Capacity Expansion Plans
Table 28. EPA & DHA (Omega 3) Ingredients Mergers & Acquisitions Activity
Table 29. United States VS China EPA & DHA (Omega 3) Ingredients Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China EPA & DHA (Omega 3) Ingredients Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China EPA & DHA (Omega 3) Ingredients Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share (2021-2026)
Table 37. China Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share (2021-2026)
Table 42. Rest of World Based EPA & DHA (Omega 3) Ingredients Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share (2021-2026)
Table 47. World EPA & DHA (Omega 3) Ingredients Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World EPA & DHA (Omega 3) Ingredients Production by Type (2021-2026) & (Tons)
Table 49. World EPA & DHA (Omega 3) Ingredients Production by Type (2027-2032) & (Tons)
Table 50. World EPA & DHA (Omega 3) Ingredients Production Value by Type (2021-2026) & (USD Million)
Table 51. World EPA & DHA (Omega 3) Ingredients Production Value by Type (2027-2032) & (USD Million)
Table 52. World EPA & DHA (Omega 3) Ingredients Average Price by Type (2021-2026) & (US$/kg)
Table 53. World EPA & DHA (Omega 3) Ingredients Average Price by Type (2027-2032) & (US$/kg)
Table 54. World EPA & DHA (Omega 3) Ingredients Production Value by Source, (USD Million), 2021 & 2025 & 2032
Table 55. World EPA & DHA (Omega 3) Ingredients Production by Source (2021-2026) & (Tons)
Table 56. World EPA & DHA (Omega 3) Ingredients Production by Source (2027-2032) & (Tons)
Table 57. World EPA & DHA (Omega 3) Ingredients Production Value by Source (2021-2026) & (USD Million)
Table 58. World EPA & DHA (Omega 3) Ingredients Production Value by Source (2027-2032) & (USD Million)
Table 59. World EPA & DHA (Omega 3) Ingredients Average Price by Source (2021-2026) & (US$/kg)
Table 60. World EPA & DHA (Omega 3) Ingredients Average Price by Source (2027-2032) & (US$/kg)
Table 61. World EPA & DHA (Omega 3) Ingredients Production Value by Grade, (USD Million), 2021 & 2025 & 2032
Table 62. World EPA & DHA (Omega 3) Ingredients Production by Grade (2021-2026) & (Tons)
Table 63. World EPA & DHA (Omega 3) Ingredients Production by Grade (2027-2032) & (Tons)
Table 64. World EPA & DHA (Omega 3) Ingredients Production Value by Grade (2021-2026) & (USD Million)
Table 65. World EPA & DHA (Omega 3) Ingredients Production Value by Grade (2027-2032) & (USD Million)
Table 66. World EPA & DHA (Omega 3) Ingredients Average Price by Grade (2021-2026) & (US$/kg)
Table 67. World EPA & DHA (Omega 3) Ingredients Average Price by Grade (2027-2032) & (US$/kg)
Table 68. World EPA & DHA (Omega 3) Ingredients Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World EPA & DHA (Omega 3) Ingredients Production by Application (2021-2026) & (Tons)
Table 70. World EPA & DHA (Omega 3) Ingredients Production by Application (2027-2032) & (Tons)
Table 71. World EPA & DHA (Omega 3) Ingredients Production Value by Application (2021-2026) & (USD Million)
Table 72. World EPA & DHA (Omega 3) Ingredients Production Value by Application (2027-2032) & (USD Million)
Table 73. World EPA & DHA (Omega 3) Ingredients Average Price by Application (2021-2026) & (US$/kg)
Table 74. World EPA & DHA (Omega 3) Ingredients Average Price by Application (2027-2032) & (US$/kg)
Table 75. dsm-firmenich Basic Information, Manufacturing Base and Competitors
Table 76. dsm-firmenich Major Business
Table 77. dsm-firmenich EPA & DHA (Omega 3) Ingredients Product and Services
Table 78. dsm-firmenich EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. dsm-firmenich Recent Developments/Updates
Table 80. dsm-firmenich Competitive Strengths & Weaknesses
Table 81. KD Pharma Basic Information, Manufacturing Base and Competitors
Table 82. KD Pharma Major Business
Table 83. KD Pharma EPA & DHA (Omega 3) Ingredients Product and Services
Table 84. KD Pharma EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. KD Pharma Recent Developments/Updates
Table 86. KD Pharma Competitive Strengths & Weaknesses
Table 87. Croda Basic Information, Manufacturing Base and Competitors
Table 88. Croda Major Business
Table 89. Croda EPA & DHA (Omega 3) Ingredients Product and Services
Table 90. Croda EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Croda Recent Developments/Updates
Table 92. Croda Competitive Strengths & Weaknesses
Table 93. BASF Basic Information, Manufacturing Base and Competitors
Table 94. BASF Major Business
Table 95. BASF EPA & DHA (Omega 3) Ingredients Product and Services
Table 96. BASF EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. BASF Recent Developments/Updates
Table 98. BASF Competitive Strengths & Weaknesses
Table 99. Yuwang Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Yuwang Pharma Major Business
Table 101. Yuwang Pharma EPA & DHA (Omega 3) Ingredients Product and Services
Table 102. Yuwang Pharma EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Yuwang Pharma Recent Developments/Updates
Table 104. Yuwang Pharma Competitive Strengths & Weaknesses
Table 105. Corbion Basic Information, Manufacturing Base and Competitors
Table 106. Corbion Major Business
Table 107. Corbion EPA & DHA (Omega 3) Ingredients Product and Services
Table 108. Corbion EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Corbion Recent Developments/Updates
Table 110. Corbion Competitive Strengths & Weaknesses
Table 111. GC Rieber VivoMega Basic Information, Manufacturing Base and Competitors
Table 112. GC Rieber VivoMega Major Business
Table 113. GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Product and Services
Table 114. GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. GC Rieber VivoMega Recent Developments/Updates
Table 116. GC Rieber VivoMega Competitive Strengths & Weaknesses
Table 117. Pelagia (EPAX) Basic Information, Manufacturing Base and Competitors
Table 118. Pelagia (EPAX) Major Business
Table 119. Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Product and Services
Table 120. Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Pelagia (EPAX) Recent Developments/Updates
Table 122. Pelagia (EPAX) Competitive Strengths & Weaknesses
Table 123. Golden Omega Basic Information, Manufacturing Base and Competitors
Table 124. Golden Omega Major Business
Table 125. Golden Omega EPA & DHA (Omega 3) Ingredients Product and Services
Table 126. Golden Omega EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Golden Omega Recent Developments/Updates
Table 128. Golden Omega Competitive Strengths & Weaknesses
Table 129. TASA Basic Information, Manufacturing Base and Competitors
Table 130. TASA Major Business
Table 131. TASA EPA & DHA (Omega 3) Ingredients Product and Services
Table 132. TASA EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. TASA Recent Developments/Updates
Table 134. TASA Competitive Strengths & Weaknesses
Table 135. KinOmega Biopharm Basic Information, Manufacturing Base and Competitors
Table 136. KinOmega Biopharm Major Business
Table 137. KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Product and Services
Table 138. KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. KinOmega Biopharm Recent Developments/Updates
Table 140. KinOmega Biopharm Competitive Strengths & Weaknesses
Table 141. Omega Protein Basic Information, Manufacturing Base and Competitors
Table 142. Omega Protein Major Business
Table 143. Omega Protein EPA & DHA (Omega 3) Ingredients Product and Services
Table 144. Omega Protein EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Omega Protein Recent Developments/Updates
Table 146. Omega Protein Competitive Strengths & Weaknesses
Table 147. Huatai Phrama Basic Information, Manufacturing Base and Competitors
Table 148. Huatai Phrama Major Business
Table 149. Huatai Phrama EPA & DHA (Omega 3) Ingredients Product and Services
Table 150. Huatai Phrama EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Huatai Phrama Recent Developments/Updates
Table 152. Huatai Phrama Competitive Strengths & Weaknesses
Table 153. AlaskOmega (Wiley Companies) Basic Information, Manufacturing Base and Competitors
Table 154. AlaskOmega (Wiley Companies) Major Business
Table 155. AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Product and Services
Table 156. AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. AlaskOmega (Wiley Companies) Recent Developments/Updates
Table 158. AlaskOmega (Wiley Companies) Competitive Strengths & Weaknesses
Table 159. Jiangsu Auqi Marine Biotechnology Basic Information, Manufacturing Base and Competitors
Table 160. Jiangsu Auqi Marine Biotechnology Major Business
Table 161. Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Product and Services
Table 162. Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Jiangsu Auqi Marine Biotechnology Recent Developments/Updates
Table 164. Jiangsu Auqi Marine Biotechnology Competitive Strengths & Weaknesses
Table 165. Roquette Basic Information, Manufacturing Base and Competitors
Table 166. Roquette Major Business
Table 167. Roquette EPA & DHA (Omega 3) Ingredients Product and Services
Table 168. Roquette EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Roquette Recent Developments/Updates
Table 170. Roquette Competitive Strengths & Weaknesses
Table 171. Polaris Basic Information, Manufacturing Base and Competitors
Table 172. Polaris Major Business
Table 173. Polaris EPA & DHA (Omega 3) Ingredients Product and Services
Table 174. Polaris EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Polaris Recent Developments/Updates
Table 176. Polaris Competitive Strengths & Weaknesses
Table 177. Solutex Basic Information, Manufacturing Base and Competitors
Table 178. Solutex Major Business
Table 179. Solutex EPA & DHA (Omega 3) Ingredients Product and Services
Table 180. Solutex EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Solutex Recent Developments/Updates
Table 182. Solutex Competitive Strengths & Weaknesses
Table 183. Sinomega Biotech Engineering Basic Information, Manufacturing Base and Competitors
Table 184. Sinomega Biotech Engineering Major Business
Table 185. Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Product and Services
Table 186. Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Sinomega Biotech Engineering Recent Developments/Updates
Table 188. Sinomega Biotech Engineering Competitive Strengths & Weaknesses
Table 189. Xinzhou Marine Biological Products Basic Information, Manufacturing Base and Competitors
Table 190. Xinzhou Marine Biological Products Major Business
Table 191. Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Product and Services
Table 192. Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Xinzhou Marine Biological Products Recent Developments/Updates
Table 194. Xinzhou Marine Biological Products Competitive Strengths & Weaknesses
Table 195. ADM Basic Information, Manufacturing Base and Competitors
Table 196. ADM Major Business
Table 197. ADM EPA & DHA (Omega 3) Ingredients Product and Services
Table 198. ADM EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. ADM Recent Developments/Updates
Table 200. ADM Competitive Strengths & Weaknesses
Table 201. Nu-Mega (Clover) Basic Information, Manufacturing Base and Competitors
Table 202. Nu-Mega (Clover) Major Business
Table 203. Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Product and Services
Table 204. Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Nu-Mega (Clover) Recent Developments/Updates
Table 206. Nu-Mega (Clover) Competitive Strengths & Weaknesses
Table 207. Guangdong Runke Bioengineering Basic Information, Manufacturing Base and Competitors
Table 208. Guangdong Runke Bioengineering Major Business
Table 209. Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Product and Services
Table 210. Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Guangdong Runke Bioengineering Recent Developments/Updates
Table 212. Guangdong Runke Bioengineering Competitive Strengths & Weaknesses
Table 213. Nissui Basic Information, Manufacturing Base and Competitors
Table 214. Nissui Major Business
Table 215. Nissui EPA & DHA (Omega 3) Ingredients Product and Services
Table 216. Nissui EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. Nissui Recent Developments/Updates
Table 218. Nissui Competitive Strengths & Weaknesses
Table 219. Cabio Biotech Basic Information, Manufacturing Base and Competitors
Table 220. Cabio Biotech Major Business
Table 221. Cabio Biotech EPA & DHA (Omega 3) Ingredients Product and Services
Table 222. Cabio Biotech EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. Cabio Biotech Recent Developments/Updates
Table 224. Cabio Biotech Competitive Strengths & Weaknesses
Table 225. Skuny Bioscience Basic Information, Manufacturing Base and Competitors
Table 226. Skuny Bioscience Major Business
Table 227. Skuny Bioscience EPA & DHA (Omega 3) Ingredients Product and Services
Table 228. Skuny Bioscience EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Skuny Bioscience Recent Developments/Updates
Table 230. Skuny Bioscience Competitive Strengths & Weaknesses
Table 231. Fermentalg Basic Information, Manufacturing Base and Competitors
Table 232. Fermentalg Major Business
Table 233. Fermentalg EPA & DHA (Omega 3) Ingredients Product and Services
Table 234. Fermentalg EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Fermentalg Recent Developments/Updates
Table 236. Fermentalg Competitive Strengths & Weaknesses
Table 237. Renpu Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 238. Renpu Pharmaceuticals Major Business
Table 239. Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Product and Services
Table 240. Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 241. Renpu Pharmaceuticals Recent Developments/Updates
Table 242. Renpu Pharmaceuticals Competitive Strengths & Weaknesses
Table 243. Xiamen HUISON Biotech Basic Information, Manufacturing Base and Competitors
Table 244. Xiamen HUISON Biotech Major Business
Table 245. Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Product and Services
Table 246. Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 247. Xiamen HUISON Biotech Recent Developments/Updates
Table 248. Xiamen HUISON Biotech Competitive Strengths & Weaknesses
Table 249. Xiamen Kingdomway Basic Information, Manufacturing Base and Competitors
Table 250. Xiamen Kingdomway Major Business
Table 251. Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Product and Services
Table 252. Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 253. Xiamen Kingdomway Recent Developments/Updates
Table 254. Xiamen Kingdomway Competitive Strengths & Weaknesses
Table 255. Algarithm Basic Information, Manufacturing Base and Competitors
Table 256. Algarithm Major Business
Table 257. Algarithm EPA & DHA (Omega 3) Ingredients Product and Services
Table 258. Algarithm EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 259. Algarithm Recent Developments/Updates
Table 260. Algarithm Competitive Strengths & Weaknesses
Table 261. Hubei Fuxing Biological Technology Basic Information, Manufacturing Base and Competitors
Table 262. Hubei Fuxing Biological Technology Major Business
Table 263. Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Product and Services
Table 264. Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 265. Hubei Fuxing Biological Technology Recent Developments/Updates
Table 266. Hubei Fuxing Biological Technology Competitive Strengths & Weaknesses
Table 267. Global Key Players of EPA & DHA (Omega 3) Ingredients Upstream (Raw Materials)
Table 268. Global EPA & DHA (Omega 3) Ingredients Typical Customers
Table 269. EPA & DHA (Omega 3) Ingredients Typical Distributors
LIST OF FIGURES
Figure 1. EPA & DHA (Omega 3) Ingredients Picture
Figure 2. World EPA & DHA (Omega 3) Ingredients Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World EPA & DHA (Omega 3) Ingredients Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 5. World EPA & DHA (Omega 3) Ingredients Average Price (2021-2032) & (US$/kg)
Figure 6. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Region (2021-2032)
Figure 7. World EPA & DHA (Omega 3) Ingredients Production Market Share by Region (2021-2032)
Figure 8. North America EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 9. Europe EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 10. China EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 11. Japan EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 12. South America EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 13. EPA & DHA (Omega 3) Ingredients Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 16. World EPA & DHA (Omega 3) Ingredients Consumption Market Share by Region (2021-2032)
Figure 17. United States EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 18. China EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 19. Europe EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 20. Japan EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 21. South Korea EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 22. ASEAN EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 23. India EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 24. Producer Shipments of EPA & DHA (Omega 3) Ingredients by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for EPA & DHA (Omega 3) Ingredients Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for EPA & DHA (Omega 3) Ingredients Markets in 2025
Figure 27. United States VS China: EPA & DHA (Omega 3) Ingredients Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: EPA & DHA (Omega 3) Ingredients Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: EPA & DHA (Omega 3) Ingredients Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share 2025
Figure 31. China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share 2025
Figure 32. Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share 2025
Figure 33. World EPA & DHA (Omega 3) Ingredients Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Type in 2025
Figure 35. EPA
Figure 36. DHA
Figure 37. World EPA & DHA (Omega 3) Ingredients Production Market Share by Type (2021-2032)
Figure 38. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Type (2021-2032)
Figure 39. World EPA & DHA (Omega 3) Ingredients Average Price by Type (2021-2032) & (US$/kg)
Figure 40. World EPA & DHA (Omega 3) Ingredients Production Value by Source, (USD Million), 2021 & 2025 & 2032
Figure 41. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Source in 2025
Figure 42. Fish Oil EPA and DHA
Figure 43. Algae Oil EPA and DHA
Figure 44. Others
Figure 45. World EPA & DHA (Omega 3) Ingredients Production Market Share by Source (2021-2032)
Figure 46. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Source (2021-2032)
Figure 47. World EPA & DHA (Omega 3) Ingredients Average Price by Source (2021-2032) & (US$/kg)
Figure 48. World EPA & DHA (Omega 3) Ingredients Production Value by Grade, (USD Million), 2021 & 2025 & 2032
Figure 49. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Grade in 2025
Figure 50. Food Grade
Figure 51. Pharma Grade
Figure 52. Feed Grade
Figure 53. World EPA & DHA (Omega 3) Ingredients Production Market Share by Grade (2021-2032)
Figure 54. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Grade (2021-2032)
Figure 55. World EPA & DHA (Omega 3) Ingredients Average Price by Grade (2021-2032) & (US$/kg)
Figure 56. World EPA & DHA (Omega 3) Ingredients Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Application in 2025
Figure 58. Dietary Supplements
Figure 59. Fortified Food and Beverages
Figure 60. Infant Formula
Figure 61. Pharmaceuticals
Figure 62. Pet Food
Figure 63. Others
Figure 64. World EPA & DHA (Omega 3) Ingredients Production Market Share by Application (2021-2032)
Figure 65. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Application (2021-2032)
Figure 66. World EPA & DHA (Omega 3) Ingredients Average Price by Application (2021-2032) & (US$/kg)
Figure 67. EPA & DHA (Omega 3) Ingredients Industry Chain
Figure 68. EPA & DHA (Omega 3) Ingredients Procurement Model
Figure 69. EPA & DHA (Omega 3) Ingredients Sales Model
Figure 70. EPA & DHA (Omega 3) Ingredients Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. EPA & DHA (Omega 3) Ingredients Picture
Figure 2. World EPA & DHA (Omega 3) Ingredients Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World EPA & DHA (Omega 3) Ingredients Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 5. World EPA & DHA (Omega 3) Ingredients Average Price (2021-2032) & (US$/kg)
Figure 6. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Region (2021-2032)
Figure 7. World EPA & DHA (Omega 3) Ingredients Production Market Share by Region (2021-2032)
Figure 8. North America EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 9. Europe EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 10. China EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 11. Japan EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 12. South America EPA & DHA (Omega 3) Ingredients Production (2021-2032) & (Tons)
Figure 13. EPA & DHA (Omega 3) Ingredients Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 16. World EPA & DHA (Omega 3) Ingredients Consumption Market Share by Region (2021-2032)
Figure 17. United States EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 18. China EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 19. Europe EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 20. Japan EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 21. South Korea EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 22. ASEAN EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 23. India EPA & DHA (Omega 3) Ingredients Consumption (2021-2032) & (Tons)
Figure 24. Producer Shipments of EPA & DHA (Omega 3) Ingredients by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for EPA & DHA (Omega 3) Ingredients Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for EPA & DHA (Omega 3) Ingredients Markets in 2025
Figure 27. United States VS China: EPA & DHA (Omega 3) Ingredients Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: EPA & DHA (Omega 3) Ingredients Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: EPA & DHA (Omega 3) Ingredients Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share 2025
Figure 31. China Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share 2025
Figure 32. Rest of World Based Manufacturers EPA & DHA (Omega 3) Ingredients Production Market Share 2025
Figure 33. World EPA & DHA (Omega 3) Ingredients Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Type in 2025
Figure 35. EPA
Figure 36. DHA
Figure 37. World EPA & DHA (Omega 3) Ingredients Production Market Share by Type (2021-2032)
Figure 38. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Type (2021-2032)
Figure 39. World EPA & DHA (Omega 3) Ingredients Average Price by Type (2021-2032) & (US$/kg)
Figure 40. World EPA & DHA (Omega 3) Ingredients Production Value by Source, (USD Million), 2021 & 2025 & 2032
Figure 41. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Source in 2025
Figure 42. Fish Oil EPA and DHA
Figure 43. Algae Oil EPA and DHA
Figure 44. Others
Figure 45. World EPA & DHA (Omega 3) Ingredients Production Market Share by Source (2021-2032)
Figure 46. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Source (2021-2032)
Figure 47. World EPA & DHA (Omega 3) Ingredients Average Price by Source (2021-2032) & (US$/kg)
Figure 48. World EPA & DHA (Omega 3) Ingredients Production Value by Grade, (USD Million), 2021 & 2025 & 2032
Figure 49. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Grade in 2025
Figure 50. Food Grade
Figure 51. Pharma Grade
Figure 52. Feed Grade
Figure 53. World EPA & DHA (Omega 3) Ingredients Production Market Share by Grade (2021-2032)
Figure 54. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Grade (2021-2032)
Figure 55. World EPA & DHA (Omega 3) Ingredients Average Price by Grade (2021-2032) & (US$/kg)
Figure 56. World EPA & DHA (Omega 3) Ingredients Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Application in 2025
Figure 58. Dietary Supplements
Figure 59. Fortified Food and Beverages
Figure 60. Infant Formula
Figure 61. Pharmaceuticals
Figure 62. Pet Food
Figure 63. Others
Figure 64. World EPA & DHA (Omega 3) Ingredients Production Market Share by Application (2021-2032)
Figure 65. World EPA & DHA (Omega 3) Ingredients Production Value Market Share by Application (2021-2032)
Figure 66. World EPA & DHA (Omega 3) Ingredients Average Price by Application (2021-2032) & (US$/kg)
Figure 67. EPA & DHA (Omega 3) Ingredients Industry Chain
Figure 68. EPA & DHA (Omega 3) Ingredients Procurement Model
Figure 69. EPA & DHA (Omega 3) Ingredients Sales Model
Figure 70. EPA & DHA (Omega 3) Ingredients Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
